ICU Medical Inc. (ICUI)
161.00
2.85 (1.80%)
At close: Jan 14, 2025, 3:59 PM
161.08
0.05%
After-hours Jan 14, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 65.2 |
| Market Cap | 3.94B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | -4.55 |
| PE Ratio (ttm) | -35.38 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 257.72 |
| Volume | 92,732 |
| Avg. Volume (20D) | 219,226 |
| Open | 158.94 |
| Previous Close | 158.15 |
| Day's Range | 157.58 - 161.66 |
| 52-Week Range | 86.80 - 196.26 |
| Beta | undefined |
About ICUI
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy and critical care applications worldwide. The company's infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; SwabCap and SwabTip disinfecting caps; Tego hemodialysis connectors; ClearGuard HD, an antimicrobial barrier cap for h...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Mar 31, 1992
Employees 14,000
Stock Exchange NASDAQ
Ticker Symbol ICUI
Website https://www.icumed.com
Analyst Forecast
According to 4 analyst ratings, the average rating for ICUI stock is "Buy." The 12-month stock price forecast is $200, which is an increase of 24.22% from the latest price.
Buy 75.00%
Hold 25.00%
Sell 0.00%
Next Earnings Release
ICU Medical Inc. is scheduled to release its earnings on Feb 25, 2025,
during market hours.
Analysts project revenue of $599.10M, reflecting a 1.91% YoY growth and earnings per share of 1.48, making a -5.73% decrease YoY.
Analysts project revenue of $599.10M, reflecting a 1.91% YoY growth and earnings per share of 1.48, making a -5.73% decrease YoY.
5 months ago ·
Source
+24.27%
ICU Medical shares are trading higher after the co...
Unlock content with
Pro Subscription
